| Selinexor |
Tablet |
II (Paddle) |
75 |
10 mM Citric Acid Buffer, pH 4.5 with 0.5% SDS |
900 |
10, 15, 20, 30 and 45 |
2021/08/19 |
| Selpercatinib |
Tablet |
II (Paddle) |
75 |
0.1 N HCl |
900 |
5, 10, 15, 20 and 30 |
2026/01/28 |
| Selpercatinib |
Capsule |
II (Paddle) |
75 |
0.1N HCl |
900 |
5, 10, 15, 20 and 30 |
2022/07/07 |
| Selumetinib |
Capsule |
II (Paddle) with sinker |
75 |
Sodium Phosphate Buffer, pH 6.5, with 0.5% Polysorbate 80 |
1000 |
10, 20, 30, 45 and 60 |
2022/07/07 |
| Semaglutide |
Tablet |
II (Paddle) |
70 |
50 mM Phosphate Buffer with 0.05% Brij 35 (polyoxyethylene lauryl ether), pH 6.8 |
500 |
10, 15, 20, 30, 45, 60 and 75 |
2021/08/19 |
| Semaglutide (1.5 mg, 4 mg, 9 mg, and 25 mg) |
Tablet |
I (Basket) |
75 |
50 mM Potassium Phosphate Buffer, pH 6.8, 10 mM Sodium Thiosulphate with 0.05% Brij 35 |
500 |
3, 5, 10, 12, 15 and 20 |
2026/03/25 |
| Sephience |
Powder |
II (Paddle) |
75 |
Phosphate Buffer, pH 6.8 |
900 |
5, 10, 15, 20, 30, 45 and 60 |
2026/03/25 |
| Sertraline HCl |
Capsule |
II (Paddle) with sinker |
75 |
0.1 N HCl |
900 |
10, 15, 20, 30 and 45 |
2023/07/07 |
| Sertraline HCl |
Tablet |
II (Paddle) |
75 |
0.05 M Sodium Acetate Buffer, pH 4.5 |
900 |
10, 20, 30 and 45 |
2004/02/20 |
| Sevabertinib |
Tablet |
II (Paddle) |
50 |
Phsophate Buffer, pH 6.8 with 0.3% SDS |
900 |
5, 10, 15, 20, 30, 45 and 60 |
2026/03/25 |
| Sevelamer Carbonate |
Tablet |
|
|
Disintegration Testing in 0.1 N HCl as per USP <701> |
|
|
2008/10/06 |
| Sevelamer HCl |
Capsule |
|
|
Disintegration Testing in 0.1 N HCl as per USP <701> |
|
|
2008/04/09 |
| Sevelamer HCl |
Tablet |
|
|
Disintegration Testing in 0.1 N HCl as per USP <701> |
|
|
2008/04/09 |
| Sibutramine HCl |
Capsule |
II (Paddle) |
50 |
0.05 M Acetate Buffer, pH 4.0 |
500 |
10, 20, 30, 45 and 60 |
2004/02/25 |
| Sildenafil Citrate |
Tablet |
I (Basket) |
100 |
0.01 N HCl |
900 |
5, 10, 15 and 30 |
2006/03/04 |
| Sildenafil Citrate |
Film |
V (Paddle over Disk) |
50 |
McIvaine Buffer, pH 5.0 |
900 |
5, 10, 15, 20, 30, 45 and 60 |
2026/03/25 |
| Sildenafil Citrate |
Suspension |
II (Paddle) |
50 |
McIlvaine Buffer, pH 5.0 |
500 |
5, 10, 15, 20 and 30 |
2015/05/28 |
| Silodosin |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Simeprevir Sodium |
Capsule |
II (Paddle) |
75 |
0.05 M Phosphate Buffer, pH 6.8 with 1.0% polysorbate 20 |
900 |
10, 15, 20, 30 and 45 |
2015/05/28 |
| Simvastatin |
Tablet |
|
|
Refer to USP |
|
|
2007/06/18 |